Iranian Journal of Blood and Cancer
Iranian Journal of Blood and Cancer
Medical Sciences
http://ijbc.ir
1
admin
2008-4595
2008-4609
8
10.61882/ijbc
14
2008-4595
13
en
jalali
1393
8
1
gregorian
2014
11
1
7
1
online
1
fulltext
en
Prevention from Doxorubicin Cardiotoxicity by Available Protective Agents in Iran
Pediatric Hematology & Oncology
Pediatric Hematology & Oncology
نامه به ویراستار
Letter to Editor
Doxorubicin, used in pediatric chemotherapy regimens, has cardiotoxic effects. Dexrazoxane is co-administrated with doxorubicin to prevent its cardiotoxicity. Here we have explored some alternative food or drugs to be used in absence of dexrazoxane since it’s not readily available in Iran at this time.
Keywords: Pediatric, chemotherapy, doxorubicin, cardiotoxicity, dexrazoxane, Iran.
Pediatric, chemotherapy, doxorubicin, cardiotoxicity, dexrazoxane, Iran.
43
44
http://ijbc.ir/browse.php?a_code=A-10-9-23&slc_lang=en&sid=1
Abdolkarimi
B
10031947532846002701
10031947532846002701
Yes